Merck is a leading global biopharmaceutical company that has been inventing for life for more than a century, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola. This site is intended for residents of the United States and its territories. For more information, visit www.merck.com.
Merck
Venture CapitalMerck is a leading global biopharmaceutical company that has been inventing for life for more than a century, bringing forward medicines and vaccines for many of the world's most challenging diseases.
29
Total Investments
28
Portfolio Companies
-
Exits
3
Industries
General Information
Company Overview
Investment Criteria
•••••• •••••• ••••••
About Merck
Recent Investments (29)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Acquisition | •••••• | Jan 2026 | |
| Seed | •••••• | Oct 2025 | |
| Late Vc | •••••• | Apr 2025 | |
| Series A | •••••• | Dec 2024 | |
| Post Ipo Equity | •••••• | Dec 2024 | |
|
|
Acquisition | •••••• | May 2024 |
|
|
Seed | •••••• | Nov 2023 |
|
|
Grant | •••••• | Aug 2023 |
|
|
Venture Round | •••••• | May 2023 |
|
|
Seed Round | •••••• | Mar 2023 |
Latest News
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.